Pulmonary alveolar microlithiasis
Last updated 18 Aug 2020
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
Pulmonary alveolar microlithiasis is a disorder in which many tiny fragments (microliths) of a compound called calcium phosphate gradually accumulate in the small air sacs (alveoli) located throughout the lungs. These deposits eventually cause widespread damage to the alveoli and surrounding lung tissue (interstitial lung disease) that leads to breathing problems. People with this disorder can develop a persistent cough and difficulty breathing (dyspnea), especially during physical exertion. Affected individuals may also experience chest pain that worsens when coughing, sneezing, or taking deep breaths.
Video picks for Genetic conditionsVideo library
Description
Pulmonary alveolar microlithiasis is a disorder in which many tiny fragments (microliths) of a compound called calcium phosphate gradually accumulate in the small air sacs (alveoli) located throughout the lungs. These deposits eventually cause widespread damage to the alveoli and surrounding lung tissue (interstitial lung disease) that leads to breathing problems. People with this disorder can develop a persistent cough and difficulty breathing (dyspnea), especially during physical exertion. Affected individuals may also experience chest pain that worsens when coughing, sneezing, or taking deep breaths.
Pulmonary alveolar microlithiasis is usually diagnosed before age 40. Often the disorder is discovered before symptoms develop, when medical imaging is done for other reasons. The condition typically worsens slowly over many years, although some affected individuals have signs and symptoms that remain stable for long periods of time.
People with pulmonary alveolar microlithiasis can also develop calcium phosphate deposits in other organs and tissues of the body, including the kidneys, gallbladder, testes, and the valve that connects a large blood vessel called the aorta with the heart (the aortic valve). In rare cases, affected individuals have complications related to accumulation of these deposits, such as a narrowing (stenosis) of the aortic valve that can impede normal blood flow.
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal recessive. More than one pattern can apply in different cases.
Related genes
Other names
PAM
Patient picks for Genetic conditions

Chest and lungs
Pulmonary fibrosis
Pulmonary fibrosis is a serious lung disease where the tiny air sacs of the lungs (the alveoli) and the lung tissue next to the alveoli become damaged and scarred, resulting in lung fibrosis. The main symptom is shortness of breath that gradually gets worse. The cause is often not known but pulmonary fibrosis can be caused by a variety of underlying conditions. Treatments include treating any underlying cause in addition to steroids and other medicines. Increasingly lung transplantation may be considered.
by Dr Toni Hazell, FRCGP

Children's health
Congenital pulmonary airway malformation
Congenital pulmonary airway malformation (CPAM) is a rare abnormality of lung development. It is found either in unborn babies or in young babies. The name has recently changed from congenital cystic adenomatoid malformation (CCAM). It is increasingly detected by the routine ultrasound scan during pregnancy. Congenital means present from birth. Pulmonary means related to the lungs. The severity of the abnormality is very variable. Some lesions can shrink or even disappear without treatment. Some lesions cause the baby to have breathing problems very soon after birth. Some lesions cause severe problems for the baby and may have a poor outcome.
by Dr Hayley Willacy, FRCGP

Heart health and blood vessels
Pulmonary oedema
Pulmonary oedema is an excess of watery fluid in the lungs. People with sudden onset of pulmonary oedema usually need urgent admission to hospital. Treatment includes oxygen, medicines to remove the excess fluid from the lungs (diuretics), and other medicines to help the heart work more effectively. Further treatment will depend on the cause of the pulmonary oedema. Pulmonary oedema may be life-threatening, especially without urgent medical treatment.
by Dr Rosalyn Adleman, MRCGP

Chest and lungs
Chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) is a long-term condition of the lungs where the flow of air to the lungs is obstructed. Symptoms include cough and breathlessness. The condition is most often caused by smoking and the most important treatment is to stop smoking. Inhalers are commonly used to ease symptoms. Other treatments such as steroids, antibiotics, oxygen, and mucus-thinning (mucolytic) medicines are sometimes prescribed in more severe cases, or during a flare-up (exacerbation) of symptoms.
by Dr Toni Hazell, FRCGP

Heart health and blood vessels
Pulmonary embolism
A pulmonary embolism (embolus) is a serious, potentially life-threatening condition. It is due to a blockage in a blood vessel in the lungs. A pulmonary embolism (PE) can cause symptoms such as chest pain or breathlessness. It may have no symptoms and be hard to detect. A massive PE can cause collapse and death. PE usually happens due to an underlying blood clot in the leg - deep vein thrombosis (DVT). Prompt treatment is important and can be life-saving. Pregnancy, various medical conditions and medicines, immobility and major surgery all increase the risk of a PE. Anticoagulation, initially with heparin and then warfarin, or other oral blood thinning tablets, is the usual treatment for PE.
by Dr Rachel Hudson, MRCGP

Medicine
Iloprost for pulmonary arterial hypertension
Treatment with iloprost nebuliser solution will be started for you in hospital. It will be prescribed for you by a specialist doctor. Iloprost may increase your tendency to bleed (such as nosebleeds). You also may feel faint and dizzy. Do not let young children or pregnant women remain in the same room with you while you use iloprost.
by Michael Stewart, MRPharmS
Related patient information and medicines

Patient information leaflet
Coughing up blood
As a general rule, th... This leaflet discusses the main causes of coughing up blood. Why am I coughing up blood. The medical word for coughing up blood is haemoptysis. The medical term for all the air tubes is the respiratory tract. At the end of the smallest bronchioles are alveoli. Alveoli are tiny sacs that are lined by a very thin layer of.

Patient information leaflet
Pulmonary fibrosis
Pulmonary fibrosis is a serious lung disease where the tiny air sacs of the lungs (the alveoli) and the lung tissue next to the alveoli become damaged and scarred, resulting in lung fibrosis. The main symptom is shortness of breath that gradually gets worse. The cause is often not known but pulmonary fibrosis can be caused by a variety of.

Patient information leaflet
Emphysema
Emphysema is a progressive lung condition that is a form of chronic obstructive pulmonary disease. Smoking is the most common cause of emphysema. Emphysema is a lung condition that causes shortness of breath and cough. Over time, the inner walls of the air sacs in the lungs (alveoli) are weakened and the lining of the alveoli becomes damaged. This.

Patient information leaflet
Bronchiectasis
Bronchiectasis is a problem with the lungs, where you cough up lots of phlegm, (sputum): far more than usual. It is usually caused by something that has already affected the lungs, like a bad infection; but sometimes no cause is found. It generally affects older people. There are some good treatments available to keep it under control..

Patient information leaflet
Pleurisy
Pleurisy is due to inflammation of the pleura next to the lung. It is most often caused by infection with a germ (a viral infection). In these cases the pain can be severe but soon goes. Various other lung disorders can also cause a 'pleuritic pain' similar to pleurisy. A pleuritic pain is a chest pain which is typically sharp and 'stabbing' in a.

Patient information leaflet
Congenital heart disease
This normally closes after birth. If it does not close, blood can pass from the left atrium to the right. This over time gradually puts extra pressure on the right side of the heart. This condition is fully explained in the separate leaflet called Atrial Septal Defect. Patent ductus arteriosus (PDA). The ductus arteriosus is a tube which connects.
Further reading and references
- Pulmonary alveolar microlithiasis; MedlinePlus, National Library of Medicine.
- Castellana G, Castellana G, Gentile M, Castellana R, Resta O. Pulmonary alveolar microlithiasis: review of the 1022 cases reported worldwide. Eur Respir Rev. 2015 Dec;24(138):607-20. doi: 10.1183/16000617.0036-2015.
- Ferreira Francisco FA, Pereira e Silva JL, Hochhegger B, Zanetti G, Marchiori E. Pulmonary alveolar microlithiasis. State-of-the-art review. Respir Med. 2013 Jan;107(1):1-9. doi: 10.1016/j.rmed.2012.10.014. Epub 2012 Nov 23.
- Huqun, Izumi S, Miyazawa H, Ishii K, Uchiyama B, Ishida T, Tanaka S, Tazawa R, Fukuyama S, Tanaka T, Nagai Y, Yokote A, Takahashi H, Fukushima T, Kobayashi K, Chiba H, Nagata M, Sakamoto S, Nakata K, Takebayashi Y, Shimizu Y, Kaneko K, Shimizu M, Kanazawa M, Abe S, Inoue Y, Takenoshita S, Yoshimura K, Kudo K, Tachibana T, Nukiwa T, Hagiwara K. Mutations in the SLC34A2 gene are associated with pulmonary alveolar microlithiasis. Am J Respir Crit Care Med. 2007 Feb 1;175(3):263-8. doi: 10.1164/rccm.200609-1274OC. Epub 2006 Nov 9.
- Jonsson AL, Simonsen U, Hilberg O, Bendstrup E. Pulmonary alveolar microlithiasis: two case reports and review of the literature. Eur Respir Rev. 2012 Sep 1;21(125):249-56. doi: 10.1183/09059180.00009411.
- Mehta K, Dell S, Birken C, Al-Saleh S. Pulmonary Alveolar Microlithiasis. Can Respir J. 2016;2016:4938632. doi: 10.1155/2016/4938632. Epub 2016 Mar 31.
- Proesmans M, Boon M, Verbeken E, Ozcelik U, Kiper N, Van de Casseye W, De Boeck K. Pulmonary alveolar microlithiasis: a case report and review of the literature. Eur J Pediatr. 2012 Jul;171(7):1069-72. doi: 10.1007/s00431-012-1678-8. Epub 2012 Feb 4.
- Saito A, McCormack FX. Pulmonary Alveolar Microlithiasis. Clin Chest Med. 2016 Sep;37(3):441-8. doi: 10.1016/j.ccm.2016.04.007. Epub 2016 Jun 24.
- Yin X, Wang H, Wu D, Zhao G, Shao J, Dai Y. SLC34A2 Gene mutation of pulmonary alveolar microlithiasis: report of four cases and review of literatures. Respir Med. 2013 Feb;107(2):217-22. doi: 10.1016/j.rmed.2012.10.016. Epub 2012 Nov 17.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

